Related Experiment Videos
Edmonton injector: use in Córdoba, Argentina
M Pruvost1, O E De la Colina, N A Monasterolo
1Pain and Palliative Medicine Section, Hospital San Roque, Córdoba, Argentina.
Journal of Pain and Symptom Management
|December 1, 1996
Summary
The Edmonton Injector (EI) safely delivered morphine via subcutaneous injection to advanced cancer patients. This versatile, low-cost device is a viable option for palliative care in developing countries.
Area of Science:
- Palliative Care
- Oncology
- Medical Devices
Background:
- Advanced cancer patients require effective pain management.
- Subcutaneous morphine delivery is crucial for terminally ill patients.
- Access to reliable drug delivery systems is limited in developing nations.
Purpose of the Study:
- To evaluate the safety and efficacy of the Edmonton Injector (EI) for intermittent subcutaneous morphine administration.
- To assess the feasibility of using the EI for home-based palliative care.
- To determine the suitability of the EI as a low-cost alternative in resource-limited settings.
Main Methods:
- Fourteen patients with advanced cancer received morphine via subcutaneous injection using the Edmonton Injector.
- Twelve patients administered the medication at home.
- Morphine dosage ranged from 15 mg to 90 mg every 4 hours.
Main Results:
- The Edmonton Injector was used for intermittent subcutaneous morphine delivery in advanced cancer patients.
- Dosages varied from 15 mg to 90 mg every 4 hours.
- Two complications, abscess and bleeding, were reported.
Conclusions:
- The Edmonton Injector demonstrates safety, low cost, and versatility for subcutaneous morphine delivery.
- It offers a valuable alternative for managing pain in terminally ill patients, particularly in developing countries.
- The device is an ideal "injection pump" for resource-limited settings where cost is a primary consideration.